Progress on an Implantable Artificial Kidney Reported at ASN
The Kidney Project, led by Shuvo Roy, PhD and nephrologist William H. Fissell, MD, is developing a two-part, deck-of-cards sized implantable bioartificial kidney to replace dialysis. A hemofilter will remove toxins. A bioreactor containing human kidney cells will control fluid volume and blood pressure, adjust salts, and make hormones. At ASN Kidney Week 2019, the project announced that a prototype bioreactor was successfully placed in large animals with no immune reaction or blood clots—and no immunosuppression needed. The system now awaits FDA approval to do a clinical safety trial.
Read the full article » | Posted 11-16-2019
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

